GT Biopharma (GTBP) Institutional Ownership $2.15 +0.02 (+1.17%) As of 02/21/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for GT Biopharma (NASDAQ:GTBP)CurrentInstitutional OwnershipPercentage8.15%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$4.84MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$326.26K Get GTBP Insider Trade Alerts Want to know when executives and insiders are buying or selling GT Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data GTBP Institutional Buying and Selling by Quarter GT Biopharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/8/2024 DekaBank Deutsche Girozentrale978,358$2.77M0.0%-10.5%69.044% 6/4/2024 DekaBank Deutsche Girozentrale1,093,645$47.45M0.1%N/A77.017% 8/2/2023 Bank of Montreal Can596,240$262K0.0%N/A1.596% 1/23/2023 Baskin Financial Services Inc.151,354$134K0.0%N/A0.466% 11/7/2022 Virtu Financial LLC24,864$44K0.0%N/A0.076% 5/5/2022 Russell Investments Group Ltd.11,007$31K0.0%N/A0.033% 5/2/2022 Allspring Global Investments Holdings LLC25,782$74K0.0%N/A0.078% 4/20/2022 Sigma Planning Corp21,400$62K0.0%N/A0.067% 2/14/2022 Gordian Capital Singapore Pte Ltd35,000$107K0.1%N/A0.114% 2/9/2022 Compagnie Lombard Odier SCmA30,000$92K0.0%+100.0%0.098% Get the Latest News and Ratings for GTBP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for GT Biopharma and its competitors with MarketBeat's FREE daily newsletter. 2/4/2022 Crumly & Associates Inc.32,163$85K0.0%N/A0.105% 2/3/2022 Brighton Jones LLC11,288$34K0.0%N/A0.037% 1/31/2022 Commonwealth Equity Services LLC11,052$33K0.0%N/A0.036% 11/16/2021 Two Sigma Advisers LP51,100$344K0.0%+243.0%0.242% 11/16/2021 Two Sigma Investments LP162,823$1.10M0.0%N/A0.771% 11/15/2021 Marshall Wace LLP16,577$112K0.0%-35.7%0.078% 11/15/2021 Franklin Resources Inc.28,500$192K0.0%N/A0.135% 11/12/2021 Renaissance Technologies LLC84,700$571K0.0%N/A0.401% 11/12/2021 Geode Capital Management LLC424,279$2.86M0.0%+22.4%2.008% 11/10/2021 Goldman Sachs Group Inc.52,426$353K0.0%N/A0.248% 11/9/2021BlackRock Inc.1,155,228$7.79M0.0%-18.3%5.468% 11/8/2021 State Board of Administration of Florida Retirement System18,224$123K0.0%N/A0.086% 11/8/2021 Russell Investments Group Ltd.9,642$64K0.0%N/A0.046% 11/5/2021 Welch Group LLC10,000$67K0.0%N/A0.047% 11/4/2021 Deutsche Bank AG11,400$77K0.0%-25.7%0.054% 11/2/2021 New York State Common Retirement Fund8,230$55K0.0%-59.7%0.039% 8/25/2021 Marshall Wace LLP25,792$400K0.0%N/A0.122% 8/17/2021 Metropolitan Life Insurance Co NY8,782$136K0.0%N/A0.042% 8/17/2021 MetLife Investment Management LLC11,471$178K0.0%N/A0.054% 8/17/2021 Citadel Advisors LLC510,058$7.91M0.0%N/A2.414% 8/16/2021 California State Teachers Retirement System32,878$510K0.0%N/A0.156% 8/16/2021 Charles Schwab Investment Management Inc.57,993$899K0.0%N/A0.274% 8/16/2021 State Street Corp374,704$5.81M0.0%N/A1.773% 8/16/2021 Nuveen Asset Management LLC82,151$1.27M0.0%N/A0.389% 8/16/2021 Marshall Wace LLP25,792$400K0.0%N/A0.122% 8/13/2021 Northern Trust Corp225,457$3.50M0.0%+555.6%1.067% 8/13/2021 Geode Capital Management LLC346,606$5.37M0.0%+165.8%1.641% 8/13/2021 Vanguard Group Inc.982,269$15.23M0.0%+267.0%4.649% 8/12/2021 Legal & General Group Plc2,524$39K0.0%N/A0.012% 8/12/2021 JPMorgan Chase & Co.9,155$142K0.0%N/A0.043% The FED is losing the war on inflation (Ad)It's no longer just a “guesstimate” – Inflation is indeed getting worse. And although we want to believe the Fed has a good grip on it, they don't. Right now, the suits over there are caught between a rock and a hard place. Either they watch as inflation grows, or they tear it down and send us into a full-blown recession. The kicker here is that neither of these are good for you. Whichever pill we end up with, prices will still climb higher as the value of the dollar sinks lower. The only real way out for the regular person is to increase your earning power. By increasing your income to match prices as they flare up… You’ll stay ahead of the impending doom we're running face-first into. And if you're looking for a strategy to help increase your income in 2025… I've got just the thing for you! You see, last year, I was able to grow a $10k model account to a little over $63k with 100 trade alerts But I changed my trading rules and more than doubled my results on those 100 published trades. I'm now calling them Warped Options…You can go here to give yourself a head start.8/12/2021 The Manufacturers Life Insurance Company13,758$213K0.0%N/A0.065% 8/11/2021 Bank of New York Mellon Corp58,711$910K0.0%N/A0.278% 8/11/2021BlackRock Inc.1,413,391$21.91M0.0%N/A6.690% 8/11/2021 Deutsche Bank AG15,349$237K0.0%N/A0.073% 8/10/2021 Citigroup Inc.6,134$95K0.0%N/A0.029% 8/6/2021 Ameritas Investment Partners Inc.1,870$29K0.0%N/A0.009% 8/5/2021 Rhumbline Advisers18,634$289K0.0%N/A0.088% 8/2/2021 New York State Common Retirement Fund20,400$316K0.0%N/A0.097% 8/2/2021 Advisor Group Holdings Inc.2,943$45K0.0%+108.3%0.014% 7/31/2021 Davy Global Fund Management Ltd35,113$544K0.1%+33.4%0.166% 7/15/2021 Compagnie Lombard Odier SCmA15,000$233K0.0%N/A0.071% 7/6/2021 Silverleafe Capital Partners LLC104,000$1.61M0.6%N/A0.492% 5/19/2021 Virtu Financial LLC22,741$156K0.0%N/A0.080% 5/19/2021 Squarepoint Ops LLC16,543$113K0.0%N/A0.058% 5/18/2021 Millennium Management LLC27,895$191K0.0%N/A0.098% 5/17/2021 Royal Bank of Canada24,542$167K0.0%N/A0.086% 5/12/2021 Northern Trust Corp34,387$235K0.0%N/A0.121% 5/12/2021 Geode Capital Management LLC130,388$891K0.0%N/A0.459% 5/12/2021 UBS Group AG3,918$27K0.0%N/A0.014% 5/11/2021 Davy Global Fund Management Ltd26,321$180K0.0%N/A0.093% (Data available from 1/1/2016 forward) GTBP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of GTBP shares? During the previous two years, the following institutional investors and hedge funds held shares of GT Biopharma shares: DekaBank Deutsche Girozentrale ($2.77M), Bank of Montreal Can ($262K).Learn more on GTBP's institutional investors. What percentage of GT Biopharma stock is owned by institutional investors? 8.15% of GT Biopharma stock is owned by institutional investors. Learn more on GTBP's institutional investor holdings. Which institutional investors have been buying GT Biopharma stock? The following institutional investors have purchased GT Biopharma stock in the last 24 months: DekaBank Deutsche Girozentrale ($1.09M), and Bank of Montreal Can ($596.24K). How much institutional buying is happening at GT Biopharma? Institutional investors have bought a total of 1,689,885 shares in the last 24 months. This purchase volume represents approximately $10.43M in transactions. Which GT Biopharma major shareholders have been selling company stock? The following institutional investors have sold GT Biopharma stock in the last 24 months: DekaBank Deutsche Girozentrale ($115.29K). How much institutional selling is happening at GT Biopharma? Institutional investors have sold a total of 115,287 shares in the last 24 months. This volume of shares sold represents approximately $326.26K in transactions. Related Companies NanoViricides Major Shareholders GlycoMimetics Major Shareholders Marker Therapeutics Major Shareholders Athira Pharma Major Shareholders MEI Pharma Major Shareholders Quantum Biopharma Major Shareholders Affimed Major Shareholders Sol-Gel Technologies Major Shareholders Spruce Biosciences Major Shareholders Synlogic Major Shareholders This page (NASDAQ:GTBP) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GT Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GT Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GTBP Stock Alerts